SPDL1 and cancer: A trend for higher levels in patients with malignant tumors was also observed for sPD-L1 in serum, 87.2 pg/mL (64.9–348.2 pg/mL) versus 80.2 pg/mL (72.5–123.8 pg/mL) (p = 0.054).